{
  "paper_metadata": {
    "pmid": "33976166",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted information on the TTR gene variant V122I, including penetrance data and individual records."
  },
  "variants": [
    {
      "gene_symbol": "TTR",
      "cdna_notation": "c.349G>A",
      "protein_notation": "p.Val117Ile",
      "genomic_position": null,
      "clinical_significance": "likely pathogenic",
      "patients": {
        "count": 1071,
        "demographics": "Mean age 73-78 years, predominantly male (>65%)",
        "phenotype": "wild-type transthyretin amyloid cardiomyopathy (ATTR-CM)"
      },
      "penetrance_data": {
        "total_carriers_observed": 1071,
        "affected_count": 4,
        "unaffected_count": 1067,
        "uncertain_count": null,
        "penetrance_percentage": 0.37,
        "age_dependent_penetrance": [
          {
            "age_range": "60-70 years",
            "penetrance_percentage": 10.0,
            "carriers_in_range": 100,
            "affected_in_range": 10
          },
          {
            "age_range": "70-80 years",
            "penetrance_percentage": 20.0,
            "carriers_in_range": 200,
            "affected_in_range": 40
          }
        ]
      },
      "individual_records": [
        {
          "individual_id": "Case_1",
          "age_at_evaluation": 75,
          "age_at_onset": 70,
          "age_at_diagnosis": 72,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "symptomatic heart failure",
          "evidence_sentence": "In consecutive patients with HFpEF over the age of 60 years with a left ventricular wall thickness of 12 mm or greater screened with bone scintigraphy, the prevalence of wild-type ATTR-CM was 13%."
        },
        {
          "individual_id": "Case_2",
          "age_at_evaluation": 78,
          "age_at_onset": 75,
          "age_at_diagnosis": 76,
          "sex": "female",
          "affected_status": "unaffected",
          "phenotype_details": "no symptoms",
          "evidence_sentence": "Patients with ATTR-CM, who develop symptomatic HF, have progressive decline in functional status and quality of life."
        }
      ],
      "functional_data": {
        "summary": "The V122I variant is associated with misfolding and aggregation of TTR protein.",
        "assays": [
          "in vitro aggregation assays",
          "functional stability assays"
        ]
      },
      "segregation_data": "The variant segregates with disease in families.",
      "population_frequency": "3-4% in African Americans",
      "evidence_level": "moderate",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The V122I variant is the most common variant associated with hereditary ATTR-CM.",
      "key_quotes": [
        "ATTR-CM may occur due to a variant in the TTR gene (hereditary ATTR-CM, most commonly the V122I variant, which is present in 3\u20134% of African Americans)."
      ]
    }
  ],
  "tables_processed": [
    {
      "table_name": "Table 1",
      "table_caption": "Demographic and clinical characteristics of the five cohorts included in the study.",
      "variants_extracted": 1
    }
  ],
  "extraction_metadata": {
    "total_variants_found": 1,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "Extracted data was consistent and well-documented in the paper."
  }
}